Oncolytics Biotech Inc T.ONC

New Press Release - Oncolytics Biotech® to Participate in a Fireside Chat at Canaccord Genuity's 43rd Annual Growth Conference

SAN DIEGO and CALGARY, AB, Aug. 4, 2023 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that Chief Executive Officer Dr. Matt Coffey will participate in a fireside chat at Canaccord Genuity's 43rd Annual Growth Conference, which is taking place August 7-10, 2023...read article.

[Lesalpes29]

How to spend the new money! Somebody here think it's important to go there and something positive can come out of it? GL

[itntdf]

suppose it is possible they could say the agreement with pancan is being finalized and that one of the "conditions" in that agreement would be that oncy has $ secured to foot their part of the trial.  we know that "product" is not an issue since oncy has been producing product at scale for quiet some time.  selling those shares might show they have enough cash to

[venture009]

If securing funds for the trial was the reason for the financing why not make that statement in the original release. It would have eliminated speculation and uncertainty, which the market doesn't like. Perhaps this is beyond this managments comprehension. Now another fireside chat with Coffey sponsored by Canaccord will probably garner the same response as usual, sp down. Coffey is better to

[Lesalpes29]

Sure that the yahoo board is missing you Venture000!